220 results on '"Wilton, Lynda V."'
Search Results
2. Cardiovascular Events In Users Of Sildenafil: Results From First Phase Of Prescription Event Monitoring In England
3. Unlicensed and off Label Drug Use for Paediatric Patients
4. Underreporting of Suspected Adverse Drug Reactions to Newly Marketed ("Black Triangle") Drugs in General Practice: Observational Study
5. Safety and Drug Utilization Profile of Varenicline as Used in General Practice in England: Interim Results from a Prescription-Event Monitoring Study
6. Use and Risk Management of Carvedilol for the Treatment of Heart Failure in the Community in England: Results from a Modified Prescription-Event Monitoring Study
7. Safety Profile of Esomeprazole: Results of a Prescription-Event Monitoring Study of 11 595 Patients in England
8. A Modified Prescription-Event Monitoring Study to Assess the Introduction of Seretide Evohaler™ in England: An Example of Studying Risk Monitoring in Pharmacovigilance
9. Safety of Zafirlukast: Results of a Postmarketing Surveillance Study on 7976 Patients in England
10. Safety Profile of Rosuvastatin: Results of a Prescription-Event Monitoring Study of 11 680 Patients
11. The safety of quetiapine: results of a post-marketing surveillance study on 1728 patients in England
12. Safety profile of raloxifene as used in general practice in England: results of a prescription-event monitoring study
13. Safety profile of celecoxib as used in general practice in England: results of a prescription-event monitoring study
14. Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000
15. Relative Risk of Vaginal Candidiasis After Use of Antibiotics Compared with Antidepressants in Women: Postmarketing Surveillance Data in England
16. Pharmacovigilance study of alendronate in England
17. The Pharmacovigilance of Pantoprazole: The Results of Postmarketing Surveillance on 11 541 Patients in England
18. Automated Signal Generation in Prescription-Event Monitoring
19. A Post-Marketing Surveillance Study of Formoterol (Foradil®)1: Its Use in General Practice in England
20. Profiles of Hepatic and Dysrhythmic Cardiovascular Events Following Use of Fluoroquinolone Antibacterials: Experience from Large Cohorts from the Drug Safety Research Unit Prescription-Event Monitoring Database
21. Troglitazone and Liver Function Abnormalities: Lessons from a Prescription Event Monitoring Study and Spontaneous Reporting
22. The safety profile of tadalafil as prescribed in general practice in England: results from a prescription-event monitoring study involving 16 129 patients
23. Monitoring the Safety of Pioglitazone: Results of a Prescription-Event Monitoring Study of 12 772 Patients in England
24. Combined Pioglitazone-Insulin Use: Analysis from the Pioglitazone Prescription-Event Monitoring Study: 255.
25. A modified prescription-event monitoring study to assess the introduction of Flixotide Evohaler™ into general practice in England: an example of pharmacovigilance planning and risk monitoring†
26. An observational cohort study investigating the cardiovascular safety of tadalafil when prescribed in primary care in England: mortality due to ischaemic heart disease
27. Examination of the safety and use of apomorphine prescribed in general practice in England as a treatment for erectile dysfunction
28. Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin®
29. The Authors’ Reply
30. Safety profile of rofecoxib as used in general practice in England: results of a prescription-event monitoring study
31. A Postmarketing Surveillance Study of Gabapentin as Add-on Therapy for 3,100 Patients in England
32. Cardiovascular events in users of sildenafil : Authorsʼ reply
33. Incompleteness of Lamotrigine Data
34. Postmarketing Surveillance Of Enalapril. I: Results Of Prescription-Event Monitoring
35. Postmarketing Surveillance Of Enalapril. II: Investigation Of The Potential Role Of Enalapril In Deaths With Renal Failure
36. Comparison of incidence rates of cerebrovascular accidents and transienti schaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia
37. Prescription-event monitoring and reporting of adverse drug reactions
38. Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England
39. Unlicensed and off label drug use for paediatric patients: General practitioners prescribe SSRIs to children off label
40. The Safety Profiles of Orlistat and Sibutramine: Results of Prescription-Event Monitoring Studies in England
41. Safety of Zafirlukast
42. The safety of quetiapine: results of a post-marketing surveillance study on 1728 patients in England
43. Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia
44. Safety profile of raloxifene as used in general practice in England: results of a prescription-event monitoring study
45. The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13 554 patients in England
46. The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England
47. Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine
48. Safety profile of nicorandil—prescription-event monitoring (PEM) study
49. Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies
50. Interim report on the incidence of visual field defects in patients on long term vigabatrin therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.